← Back to Search

Treatment for Retinal Neovascularization

N/A
Waitlist Available
Led By Jeff Heier, MD
Research Sponsored by Notal Vision Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

The purpose of this study is to evaluate the ability of subjects with NV-AMD to perform sequential daily self-imaging of their eyes with the self-operated Notal Home OCT device in their homes for 90 days without on-site supervision. The study will include up to 15 subjects.

Eligible Conditions
  • Retinal Neovascularization

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Find a Location

Who is running the clinical trial?

Notal Vision Inc.Lead Sponsor
8 Previous Clinical Trials
20,779 Total Patients Enrolled
1 Trials studying Retinal Neovascularization
15 Patients Enrolled for Retinal Neovascularization
Jeff Heier, MDPrincipal InvestigatorOphthalmic Consultants of Boston, Boston, MA.
2 Previous Clinical Trials
32 Total Patients Enrolled
1 Trials studying Retinal Neovascularization
15 Patients Enrolled for Retinal Neovascularization
Nancy Holekamp, MDPrincipal InvestigatorPepose Vision Institute, Chesterfield, MO.
1 Previous Clinical Trials
32 Total Patients Enrolled
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top